Related Experiment Video
Updated: Oct 23, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression
1Medical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
Acute kidney injury (AKI) is a common clinical critical disease. Due to its high morbidity, increasing risk of complications, high mortality rate, and high medical costs, it has become a global concern for human health problems. Initially, researchers believed that kidneys have a strong ability to regenerate and repair, but studies over the past 20 years have found that kidneys damaged by AKI are often incomplete or even unable to repair. Even when serum creatinine returns to baseline levels, renal structural damage persists for a long time, leading to the development of chronic kidney disease (CKD). The mechanism of AKI-to-CKD transition has not been fully elucidated. As an important regulator of gene expression, epigenetic modifications, such as histone modification, DNA methylation, and noncoding RNAs, may play an important role in this process. Alterations in epigenetic modification are induced by hypoxia, thus promoting the expression of inflammatory factor-related genes and collagen secretion. This review elaborated the role of epigenetic modifications in AKI-to-CKD progression, the diagnostic value of epigenetic modifications biomarkers in AKI chronic outcome, and the potential role of targeting epigenetic modifications in the prevention and treatment of AKI to CKD, in order to provide ideas for the subsequent establishment of targeted therapeutic strategies to prevent the progression of renal tubular-interstitial fibrosis.
Insights
Epigenetic modifications, including DNA methylation and histone changes, are crucial in the progression from acute kidney injury (AKI) to chronic kidney disease (CKD). Targeting these epigenetic changes offers potential therapeutic strategies for preventing kidney fibrosis.
Area of Science:
- Nephrology
- Molecular Biology
- Epigenetics
Background:
- Acute kidney injury (AKI) is a critical condition with high morbidity and mortality.
- Kidney damage from AKI often leads to incomplete repair and chronic kidney disease (CKD), even after serum creatinine normalizes.
- The mechanisms driving the transition from AKI to CKD remain incompletely understood.
Purpose of the Study:
- To review the role of epigenetic modifications in the progression of AKI to CKD.
- To explore the diagnostic potential of epigenetic biomarkers for AKI's chronic outcomes.
- To discuss the therapeutic implications of targeting epigenetic modifications for AKI-to-CKD prevention.
Main Methods:
- Literature review focusing on epigenetic mechanisms in kidney injury.
- Analysis of studies investigating histone modification, DNA methylation, and noncoding RNAs in AKI-to-CKD.
- Synthesis of current understanding of hypoxia-induced epigenetic alterations.
Main Results:
- Epigenetic modifications, influenced by hypoxia, promote inflammatory gene expression and collagen secretion.
- Specific epigenetic alterations are implicated in the persistent renal structural damage following AKI.
- Epigenetic biomarkers show promise for predicting the long-term consequences of AKI.
Conclusions:
- Epigenetic modifications are key players in the AKI-to-CKD transition.
- Epigenetic biomarkers may aid in diagnosing and predicting chronic kidney outcomes after AKI.
- Targeting epigenetic pathways presents a promising therapeutic avenue to prevent renal fibrosis and CKD progression.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

